Home
AQST
AQST News

Latest Aquestive Therapeutics Inc. (AQST) News on July 26, 2024

Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study

GlobeNewswire

a day ago

Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET

GlobeNewswire

3 days ago

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET

New Strong Sell Stocks for July 11th

Zacks

16 days ago

New Strong Sell Stocks for July 11th

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

GlobeNewswire

a month ago

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows

Benzinga

a month ago

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire

a month ago

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film

Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years

Simply Wall St.

a month ago

Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years

MT Newswires

a month ago

Aquestive Therapeutics to Join Russell 3000, Russell 2000 on July 1

Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024

GlobeNewswire

a month ago

Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities

GlobeNewswire

2 months ago

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference

GlobeNewswire

2 months ago

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference

5 Small Drug Stocks to Buy From a Recovering Industry

Zacks

2 months ago

5 Small Drug Stocks to Buy From a Recovering Industry

MT Newswires

3 months ago

Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

GlobeNewswire

3 months ago

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Simply Wall St.

3 months ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

GuruFocus.com

3 months ago

Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Zacks

3 months ago

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates

Zacks

3 months ago

Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates

Associated Press Finance

3 months ago

Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Zacks

3 months ago

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

3 months ago

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for

Zacks

3 months ago

Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for

MT Newswires

3 months ago

Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire

3 months ago

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET

GlobeNewswire

3 months ago

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET

Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology

GlobeNewswire

3 months ago

Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology

Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note

Zacks

4 months ago

Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

GlobeNewswire

4 months ago

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

GlobeNewswire

4 months ago

Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know

Zacks

4 months ago

Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know

Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock

GlobeNewswire

4 months ago

Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ...

GuruFocus.com

4 months ago

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ...

Aquestive Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

4 months ago

Aquestive Therapeutics Announces Proposed Public Offering of Common Stock

Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals

Zacks

4 months ago

Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

Zacks

4 months ago

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting

GlobeNewswire

4 months ago

Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...

GuruFocus.com

4 months ago

Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ...

Aquestive Therapeutics Inc Reports Full Year 2023 Financial Results

GuruFocus.com

5 months ago

Aquestive Therapeutics Inc Reports Full Year 2023 Financial Results

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript

Aquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

Aquestive Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Aquestive Therapeutics Inc Earnings Call

Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 months ago

Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

5 months ago

Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

5 months ago

Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?

Zacks

5 months ago

Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?

Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know

Zacks

5 months ago

Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know

Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect

Zacks

5 months ago

Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect

Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET

GlobeNewswire

5 months ago

Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET

Aquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

5 months ago

Aquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to Note

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting

GlobeNewswire

5 months ago

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting

Aquestive Therapeutics (AQST) Rises Higher Than Market: Key Facts

Zacks

5 months ago

Aquestive Therapeutics (AQST) Rises Higher Than Market: Key Facts

Why Aquestive Therapeutics (AQST) Outpaced the Stock Market Today

Zacks

6 months ago

Why Aquestive Therapeutics (AQST) Outpaced the Stock Market Today

Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why

Zacks

6 months ago

Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why

Associated Press Finance

6 months ago

8x8: Fiscal Q3 Earnings Snapshot

8x8 (NASDAQ:EGHT) Reports Sales Below Analyst Estimates In Q3 Earnings

StockStory

6 months ago

8x8 (NASDAQ:EGHT) Reports Sales Below Analyst Estimates In Q3 Earnings

Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference

GlobeNewswire

6 months ago

Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference

SOUTHERN CALIFORNIA BANCORP REPORTS NET INCOME OF $4.4 MILLION FOR THE FOURTH QUARTER AND $25.9 MILLION FOR THE FULL YEAR OF 2023

GlobeNewswire

6 months ago

SOUTHERN CALIFORNIA BANCORP REPORTS NET INCOME OF $4.4 MILLION FOR THE FOURTH QUARTER AND $25.9 MILLION FOR THE FULL YEAR OF 2023

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Zacks

6 months ago

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Trinseo Announces Price Increase for PMMA Cast Sheets in Europe

Business Wire

6 months ago

Trinseo Announces Price Increase for PMMA Cast Sheets in Europe

ParkOhio Announces Quarterly Dividend

Business Wire

6 months ago

ParkOhio Announces Quarterly Dividend

Things Look Grim For Orrstown Financial Services, Inc. (NASDAQ:ORRF) After Today's Downgrade

Simply Wall St.

6 months ago

Things Look Grim For Orrstown Financial Services, Inc. (NASDAQ:ORRF) After Today's Downgrade

Thomson Reuters StreetEvents

6 months ago

Q4 2023 First Internet Bancorp Earnings Call

Ring Energy to Present at the Microcap Conference

GlobeNewswire

6 months ago

Ring Energy to Present at the Microcap Conference

First Internet (INBK) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

6 months ago

First Internet (INBK) Reports Q4 Earnings: What Key Metrics Have to Say

First Internet Bancorp (INBK) Q4 Earnings and Revenues Surpass Estimates

Zacks

6 months ago

First Internet Bancorp (INBK) Q4 Earnings and Revenues Surpass Estimates

Associated Press Finance

6 months ago

Horizon Bancorp: Q4 Earnings Snapshot

Horizon Bancorp, Inc. Announces Fourth Quarter and Full Year 2023 Results, Successfully Executes Balance Sheet Restructuring for Future Earnings Growth

GlobeNewswire

6 months ago

Horizon Bancorp, Inc. Announces Fourth Quarter and Full Year 2023 Results, Successfully Executes Balance Sheet Restructuring for Future Earnings Growth

Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

6 months ago

Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You Trade

Sunoco (SUN) and NuStar Join Forces for a 7.3B All-Equity Merger

Zacks

6 months ago

Sunoco (SUN) and NuStar Join Forces for a 7.3B All-Equity Merger

Best Value Stocks to Buy for January 23rd

Zacks

6 months ago

Best Value Stocks to Buy for January 23rd

AMSC to Report Third Quarter Fiscal Year 2023 Financial Results on January 24, 2024

GlobeNewswire

6 months ago

AMSC to Report Third Quarter Fiscal Year 2023 Financial Results on January 24, 2024

Business Wire

6 months ago

Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in December

Ames National (NASDAQ:ATLO) Has Affirmed Its Dividend Of $0.27

Simply Wall St.

6 months ago

Ames National (NASDAQ:ATLO) Has Affirmed Its Dividend Of $0.27

Trinseo Announces Release Date and Conference Call for its Fourth Quarter and Full Year 2023 Financial Results

Business Wire

6 months ago

Trinseo Announces Release Date and Conference Call for its Fourth Quarter and Full Year 2023 Financial Results

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode

InvestorPlace

6 months ago

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) top owners are individual investors with 60% stake, while 27% is held by institutions

Simply Wall St.

6 months ago

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) top owners are individual investors with 60% stake, while 27% is held by institutions

American Superconductor (AMSC) Surges 5.4%: Is This an Indication of Further Gains?

Zacks

6 months ago

American Superconductor (AMSC) Surges 5.4%: Is This an Indication of Further Gains?

Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for Investors

Zacks

6 months ago

Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for Investors

Business Wire

6 months ago

Transphorm to Present at the 26th Annual Needham Growth Conference

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?

Zacks

6 months ago

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?

Sleep Number (NASDAQ:SNBR) stock falls 18% in past week as three-year earnings and shareholder returns continue downward trend

Simply Wall St.

6 months ago

Sleep Number (NASDAQ:SNBR) stock falls 18% in past week as three-year earnings and shareholder returns continue downward trend

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

Zacks

6 months ago

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

Public companies account for 50% of Fanhua Inc.'s (NASDAQ:FANH) ownership, while individual investors account for 31%

Simply Wall St.

6 months ago

Public companies account for 50% of Fanhua Inc.'s (NASDAQ:FANH) ownership, while individual investors account for 31%

Here's Why Aquestive Therapeutics (AQST) Fell More Than Broader Market

Zacks

6 months ago

Here's Why Aquestive Therapeutics (AQST) Fell More Than Broader Market

Business Wire

6 months ago

BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Program’s Inception

Renesas to Acquire Transphorm to Expand its Power Portfolio with GaN Technology

Business Wire

7 months ago

Renesas to Acquire Transphorm to Expand its Power Portfolio with GaN Technology

VNET Welcomes New Executive Director to Board

PR Newswire

7 months ago

VNET Welcomes New Executive Director to Board

Barings Global Short Duration High Yield Fund Announces January 2024 Monthly Distribution of $0.1056 per Share

Business Wire

7 months ago

Barings Global Short Duration High Yield Fund Announces January 2024 Monthly Distribution of $0.1056 per Share

Ligand (LGND) Up 9% on FDA Nod for Molluscum Infection Gel

Zacks

7 months ago

Ligand (LGND) Up 9% on FDA Nod for Molluscum Infection Gel

Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer

GlobeNewswire

7 months ago

Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer

Share on Social Networks: